1. Published

   Impact of the abolition of prescription charges in Wales: a multi-level modelling approach with application to time series dispensed rate data

   Hughes, D., Alam, F., Myles, S., Hughes, D. A., Dunstan, F., Routledge, P. & Cohen, D., 1 Sept 2007.

   Research output: Contribution to conference › Paper

2. Published

   Impact of relaxing Covid-19 social distancing measures on rural North Wales: a simulation analysis

   Hughes, R. P. & Hughes, D., 14 Dec 2020, In: Frontiers in Public Health. 8, 562473.

   Research output: Contribution to journal › Article › peer-review

3. Published

   Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis.

   Hughes, D., Hughes, D. A., Al-Zubiedi, S., Hanson, A., Jorgensen, A. & Pirmohamed, M., 1 Jan 2009.

   Research output: Contribution to conference › Paper

4. Published

   Impact of non-compliance on the therapeutic coverage of risperidone – comparison of long acting injectible with oral formulations.

   Hughes, D. & Hughes, D. A., 1 Jan 2002, 2002 ed. Unknown.

   Research output: Book/Report › Commissioned report

5. Published

   Impact of non-compliance on the therapeutic coverage of oxybutynin – comparison of once- and twice-daily oral formulations.

   Hughes, D. & Hughes, D. A., 1 Jan 2002, 2002 ed. Unknown.

   Research output: Book/Report › Commissioned report

6. Published

   Impact of non-compliance on the cost-effectiveness of statin therapy

   Hughes, D., Hughes, D. A. & Bagust, A., 1 Sept 2001, In: Value in Health. 4, 6, p. 489

   Research output: Contribution to journal › Article › peer-review

7. Published

   Impact of non-compliance on the cost-effectiveness of pharmaceuticals

   Hughes, D. & Hughes, D. A., 1 Nov 2002.

   Research output: Contribution to conference › Paper

8. Published

   Impact of non-compliance on the clinical and cost-effectiveness of statins

   Hughes, D. & Hughes, D. A., 1 Nov 2001.

   Research output: Contribution to conference › Paper

9. Published

   Impact of non-adherence on the safety and efficacy of uric acid lowering therapies in the treatment of gout

   Hill McManus, D., Soto, E., Marshall, S., Lane, S. & Hughes, D., Jan 2018, In: British Journal of Clinical Pharmacology. 84, 1, p. 142-152

   Research output: Contribution to journal › Article › peer-review

10. Published

    Impact of non-adherence and flare resolution on the cost effectiveness of treatments for gout: Application of a linked pharmacometric/pharmacoeconomic model

    Hill-McManus, D., Marshall, S., Soto, E., Lane, S. & Hughes, D., Dec 2018, In: Value in Health. 21, 12, p. 1373-1381

    Research output: Contribution to journal › Article › peer-review